Foundation Medicine, Inc. (FMI) Loss Submission Form

Levi & Korsinsky notifies investors of a class action lawsuit filed in the USDC for the District of Massachusetts on behalf of shareholders of Foundation Medicine, Inc. (NASDAQ: FMI) who purchased shares between February 26, 2014 and November 3, 2015.

The complaint alleges that throughout the class period Defendants issued materially false and/or misleading statements and/or failed to disclose material information regarding: (1) the reimbursement process and likelihood of coverage for Foundation’s tumor tests by Medicare; and (2) the Company’s financial guidance. As a result of these false statements, Foundation common stock traded at artificially inflated prices during the Class Period.

On July 29, 2015, the Company disclosed that it was not making the strides obtaining coverage it had claimed to have been making during the Class Period, and that Foundation would receive no Medicare payments in 2015 for its tumor profiling tests due to a delay in receiving a local coverage determination from its regional Medicare Administrative Contractor. As a result of the delay, the Company slashed its 2015 financial guidance. Then, on November 3, 2015, the Company disclosed a further revision to the already reduced number of clinical tests it expected to report for 2015.

If you suffered a loss in Foundation you have until September 26, 2017 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.


To receive more information, please fill out the form.

Levi & Korsinsky, LLP doesn't share your information with others. There is no cost or obligation to submit. Your submission does NOT establish an attorney-client relationship.

This submission does not create an attorney-client relationship. If we believe that you might be an appropriate lead plaintiff, we will contact you to discuss whether to establish an attorney-client relationship.